Taiwan Styrene Monomer Corp (1310)
Taiwan Stock Exchange · Taiwan · prices in TWD · close of 22 Oct 2026
Key indicators
| Last close | TWD 9.590 |
|---|---|
| 52-week range | 7.040 – 13.250 |
| Return, 1 month / 3 months | +9.9% / −5.5% |
| Return, 1 year / 3 years | +8.5% / −37.3% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 51.2% |
| Worst drawdown (1 year) | -42.4% |
| Average daily value traded | 41.08M TWD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Taiwan Styrene Monomer Corp is a Taiwanese petrochemical producer based in Taipei. It manufactures styrene monomer, a basic chemical building block used to make plastics, synthetic rubber and resins, and it also produces related aromatic products such as ethylbenzene. Its customers are industrial manufacturers and chemical processors that use these materials as raw inputs for foams, packaging, coatings and other plastic goods. The company operates production facilities in Taiwan and serves both domestic and export markets.
The shares are listed on the Taiwan Stock Exchange in Taiwan under the code 1310, and the price on this page is in New Taiwan dollars (TWD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Taiwan Styrene Monomer Corp (1310) trades on the Taiwan Stock Exchange in Taiwan. It last closed at TWD 9.590 on 22 October 2026.
Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 716 of 1,101 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 8.5% and over the last three months it fell 5.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Taiwan Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.9% | ||
| From 52-week high | -21.7% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.5% | ||
| 6-month return | -2.1% | ||
| 12-month return, skipping the last month | -1.2% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 51.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -42.4% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 41.08M TWD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | +9.9% |
| 3 months | −5.5% |
| 6 months | −2.1% |
| 1 year | +8.5% |
| 3 years | −37.3% |
| 5 years | −45.9% |
Signals
| 50-day / 200-day average | 8.924 / 9.323 |
|---|---|
| Golden / death cross (60 days) | Death, 44 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.373 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Oct 2023 | TWD 0.2000 |
| 14 Sep 2022 | TWD 0.1500 |
| 22 Jul 2021 | TWD 0.5000 |
| 17 Jul 2020 | TWD 1.0000 |
| 26 Aug 2019 | TWD 2.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Taiwan Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.